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In the 20th  century the study of life was generally
approached with a reductionistic approach: analysing the
simple and extrapolating to more complex systems.
Thanks to this strategy the most important functions of a
living organism have been dissected and elucidated: the
structure of DNA, the complex machinery subserving the
synthesis of proteins, the mechanism for the utilization of
food and the generation of energy. On the therapeutic
side, the discovery of sulphamides and antibiotics, of spe-
cific vaccines directed against the most dangerous diseases
or the synthesis of tranquillizers and anti-psychotics in
the field of neurology and psychiatry, provided the basis
for a modern, socially oriented medicine. The paradigm
for such a strategic approach to biology was the "dogma"
proposed by Tatum and Beadle: one gene, one protein,
one function.
In the twenty first century we know that this, as well as
many other biological dogmas, are obsolete or are
doomed to die. Thus, for instance, it is presently a well
established notion that one gene may give rise to several
proteins and each of these proteins may undergo several
post-translational modifications conferring distinct func-
tional activities. These findings, in turn, provide a general
clue as to why, although the human genome has a
number of genes similar to those of a worm such as C. ele-
gans, yet the number and versatilities of proteins and cor-
responding functions are incomparable in the two
organisms. Thus, each gene could be compared, to some
extent, to a sort of kaleidoscope; as it is sufficient to
change the view of a kaleidoscope by slightly moving its
position, the expression of a gene into a given functional
protein entity may be modulated in a variety of functions
according to the developmental stage, cell type, and needs
in relationship with environment.
These findings and the impressive, often revolutionary
technical achievements of the last two decades, induced
experimental scientists and theoretical biologists to device
novel strategies and epistemological approaches.
We wish to briefly discuss, as an example, the evolution of
the studies on NGF (nerve growth factor) and eventually
try to extrapolate these short considerations to biology at
large in the 21st century.
In the fifties and subsequent few decades, the discovery by
one of us (RLM) of this growth factor [1,2], followed by
the characterization of its functional properties [3-6] was
a typical fruit of a reductionistic success: identifying a sin-
gle substance, demonstrating its diffusible nature and
showing its specific function of inducing the differentia-
tion of two types of neurons constitutive of sympathetic
and sensory ganglia. The subsequent experimental
attempt was again a typical case of a reductionistic success:
devising an in vitro culture system, to replace the complex
and time consuming in vivo experiments carried out in
chick embryo, in order to assess the presence of this
"nerve growth promoting activity" – subsequently identi-
fied as nerve growth factor (NGF) – primarily in sarcoma
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and subsequently in tissues and biological fluids. This
attempt ended with an in vitro bioassay which, within 18–
24 hours, allowed to detect NGF activity evidenced by an
impressive halo of nerve fibers. This was an even more
stringent case of a successful reductionistic approach.
In the last decade of the past century the studies on NGF
took a route which presently induces a growing number of
laboratories to carry out systemic, "holistic" strategies.
Thus, for instance, the properties of NGF receptors,
endowed with completely different structure, functional
properties and mechanism of action – to the extent, for
instance, that they may exert both pro and anti-apoptotic
actions via activation of a plethora of intracellular path-
ways – [7,8] need today a novel approach to answer ques-
tions such as: how many different genes are involved in
such a complex pattern of activities, considering, for
instance, that an anti-apoptotic pathway generally
involves hundreds of different genes and proteins? In
order to put together in a unique, comprehensible picture,
all the data that are emerging in this field of investiga-
tions, a "global" approach with highly sophisticated tech-
niques is mandatory.
On the other side, the broadening of studies on NGF tar-
get cells, which in the first 2–3 decades after its discovery
were confined to sensory and sympathetic neurons, to
cholinergic and possibly other neurons of the central
nervous system, followed by the demonstration that sev-
eral other cell types belonging to the endocrine and
immune systems are target of NGF action, also requires a
systemic strategy, to frame the whole populations of target
cells into an "organismic" view of NGF functions and
mechanism of action [9].
As mentioned above, in the 21st century, also due to the
realization of extremely sophisticated and powerful tech-
niques, such as the possibility of cloning any gene, analys-
ing the expression of thousands of genes and of the
corresponding coded proteins within the context of a spe-
cific cellular function, investigating the whole complex
machinery linking energy metabolism to modulation of
gene expression, neurobiologists must adopt novel strate-
gies and technical procedures. The term that summarizes
such an approach is "systems neurobiology" and the met-
aphor that better fits with such systemic strategy is that a
single protein is to a neuron as a neuron is to whole brain.
Accordingly, both for analysing a neuron – which is con-
stituted by thousands of proteins – and for studying the
function of brain – composed of billions of neurons -, it
is mandatory to resort to proper techniques such as
genomics, proteomics or transcriptomics, which, by defi-
nition, involve the contemporaneous analysis of hun-
dreds or thousands of genes and/or of the corresponding
coded proteins or metabolic products. Thus, considering
the wholeness of cellular systems, adopting proteomics or
functional genomics attacks might be as important for our
understanding of brain functions as, for example, the
wholeness of economical markets is to the study of macr-
oeconomics.
From this point of view this volume is a living testimony
of a novel attack to neurobiological problems, and a vari-
ety of extremely interesting problems constitute the bulk
of the assay. The modular system approach to investigate
the mechanisms involved in apoptotic processes; the
compelling need to elucidate how mRNAs and proteins
are addressed to their specific sites of action along axons
and dendrites up to their final destination at synaptic
structures; how these polymeric structures act as multi-
sensor devices of neurotransmission and the way the stor-
age of synaptic activities can be exchanged and integrated
to provide memories into a larger scale; and, last but not
least, the role played by non coding RNA in brain. All
these topics are dealt with in the volume with interesting
and novel findings and hypothesises.
Another problem of great impact deals with parameter
estimation in signalling pathway modelling, and with
how enzyme kinetics and metabolic fluxes in general con-
tribute to the control of cell operation. Computational
frameworks able to integrate data from multiple sources
are discussed as a tool for unravelling the biological mech-
anisms underlying the regulation of gene expression.
Finally, a particular welcome is to be addressed to the long
lasting case of mathematics dealing with biological prob-
lems. The entry of this discipline into the biological scene
was in past decades discouraged by the paucity of data and
by the even more remote possibility of analysing them in
a comprehensive fashion. For this reason a theoretical
biology was a hazardous task and the few attempts involv-
ing this discipline were generally unsuccessful. Nowadays,
these drawbacks can be overcome by the impressive col-
lection of data available on a specific experimental issue
and by the availability of extremely powerful computers.
Thus, the mathematical modelling of neuron develop-
ment and of signal transduction pathways that are dis-
cussed in two distinct chapters may offer new vistas to the
biological landscapes. The last article shows how the com-
ing of age of computational systems neurobiology entails
the need of automated support to handle formal models
and of developing standard and guidelines to maximise
the diffusion of its scientific production.
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